Business Segment Information (Tables)

6 Months Ended

Jul. 01, 2017

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information

	Three Months Ended						Six Months Ended
	July 1,			July 2,			July 1,			July 2,
(In millions)	2017			2016			2017			2016
Revenues
Life Sciences Solutions	$	1,404.6		$	1,367.9		$	2,768.1		$	2,585.6
Analytical Instruments	1,165.8			793.9			2,217.8			1,553.2
Specialty Diagnostics	861.8			851.3			1,728.2			1,705.9
Laboratory Products and Services	1,792.5			1,719.7			3,491.5			3,368.5
Eliminations	(234.7		)	(197.6		)	(450.6		)	(383.2		)
Consolidated revenues	4,990.0			4,535.2			9,755.0			8,830.0
Segment Income (a)
Life Sciences Solutions	448.1			389.6			882.0			740.9
Analytical Instruments	232.6			144.9			424.4			256.6
Specialty Diagnostics	235.0			237.9			468.9			468.0
Laboratory Products and Services	246.7			259.8			462.9			496.7
Subtotal reportable segments (a)	1,162.4			1,032.2			2,238.2			1,962.2
Cost of revenues charges	(0.7		)	(17.4		)	(31.6		)	(28.0		)
Selling, general and administrative charges, net	(6.8		)	(3.8		)	(38.3		)	(32.7		)
Restructuring and other costs, net	(22.5		)	(35.4		)	(46.0		)	(86.0		)
Amortization of acquisition-related intangible assets	(380.9		)	(338.0		)	(748.4		)	(660.0		)
Consolidated operating income	751.5			637.6			1,373.9			1,155.5
Other expense, net (b)	(125.9		)	(116.5		)	(245.4		)	(211.4		)
Income from continuing operations before income taxes	$	625.6		$	521.1		$	1,128.5		$	944.1
Depreciation
Life Sciences Solutions	$	32.5		$	37.6		$	65.2		$	74.6
Analytical Instruments	17.2			9.9			34.1			19.5
Specialty Diagnostics	18.1			18.2			35.3			36.2
Laboratory Products and Services	29.5			31.4			59.7			60.9
Consolidated depreciation	$	97.3		$	97.1		$	194.3		$	191.2

(a) Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.

(b) The company does not allocate other expense, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information

	Three Months Ended						Six Months Ended
	July 1,			July 2,			July 1,			July 2,
(In millions)	2017			2016			2017			2016
Revenues
Life Sciences Solutions	$	1,404.6		$	1,367.9		$	2,768.1		$	2,585.6
Analytical Instruments	1,165.8			793.9			2,217.8			1,553.2
Specialty Diagnostics	861.8			851.3			1,728.2			1,705.9
Laboratory Products and Services	1,792.5			1,719.7			3,491.5			3,368.5
Eliminations	(234.7		)	(197.6		)	(450.6		)	(383.2		)
Consolidated revenues	4,990.0			4,535.2			9,755.0			8,830.0
Segment Income (a)
Life Sciences Solutions	448.1			389.6			882.0			740.9
Analytical Instruments	232.6			144.9			424.4			256.6
Specialty Diagnostics	235.0			237.9			468.9			468.0
Laboratory Products and Services	246.7			259.8			462.9			496.7
Subtotal reportable segments (a)	1,162.4			1,032.2			2,238.2			1,962.2
Cost of revenues charges	(0.7		)	(17.4		)	(31.6		)	(28.0		)
Selling, general and administrative charges, net	(6.8		)	(3.8		)	(38.3		)	(32.7		)
Restructuring and other costs, net	(22.5		)	(35.4		)	(46.0		)	(86.0		)
Amortization of acquisition-related intangible assets	(380.9		)	(338.0		)	(748.4		)	(660.0		)
Consolidated operating income	751.5			637.6			1,373.9			1,155.5
Other expense, net (b)	(125.9		)	(116.5		)	(245.4		)	(211.4		)
Income from continuing operations before income taxes	$	625.6		$	521.1		$	1,128.5		$	944.1
Depreciation
Life Sciences Solutions	$	32.5		$	37.6		$	65.2		$	74.6
Analytical Instruments	17.2			9.9			34.1			19.5
Specialty Diagnostics	18.1			18.2			35.3			36.2
Laboratory Products and Services	29.5			31.4			59.7			60.9
Consolidated depreciation	$	97.3		$	97.1		$	194.3		$	191.2

(a) Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.

(b) The company does not allocate other expense, net to its segments.